Literature DB >> 24790748

Successful Management of Phaeochromocytoma using Preoperative Oral Labetalol and Intraoperative Magnesium Sulphate: Report of four cases.

S B Sanath Kumar1, Rohit Date1, Nicholas Woodhouse2, Omayma El-Shafie3, Karin Nollain1.   

Abstract

Phaeochromocytoma is a rare neuroendocrine catecholamine-secreting tumour. This type of tumour poses multidimensional anaesthetic challenges as it has an unpredictable clinical course during surgical resection. The alpha-blocking agent phenoxybenzamine remained the mainstay in preoperative preparation before the introduction of beta-blocking agents. We report four cases operated between 2009-2012 at Sultan Qaboos University Hospital, Muscat, Oman. The cases were prepared with oral labetalol, as the alpha-blocking drug phenoxybenzamine was not immediately available. Responses to simulated stress were tested in the theatre before surgery. Anaesthesia was induced under invasive arterial pressure monitoring and magnesium sulphate infusion. Rare intraoperative surges in blood pressure during tumour manipulation were treated with sodium nitroprusside infusions and phentolamine boluses. All of the patients had an uneventful postoperative recovery. Preoperative treatment with labetalol has rarely been reported and can be considered as a potential therapeutic option with optimal patient monitoring if phenoxybenzamine is unavailable.

Entities:  

Keywords:  Case Report; Intraoperative Care; Labetalol; Magnesium Sulfate; Oman; Phenoxybenzamine; Phentolamine; Pheochromocytoma

Year:  2014        PMID: 24790748      PMCID: PMC3997542     

Source DB:  PubMed          Journal:  Sultan Qaboos Univ Med J        ISSN: 2075-051X


  19 in total

1.  The use of magnesium sulfate in the anesthetic management of pheochromocytoma.

Authors:  M F James
Journal:  Anesthesiology       Date:  1985-02       Impact factor: 7.892

2.  Influence of pre-operative treatment with phenoxybenzamine on the incidence of adverse cardiovascular reactions during anaesthesia and surgery for phaeochromocytoma.

Authors:  G Stenström; H Haljamäe; L E Tisell
Journal:  Acta Anaesthesiol Scand       Date:  1985-11       Impact factor: 2.105

3.  Hypertensive response to labetalol in phaeochromocytoma.

Authors:  R S Briggs; A J Birtwell; J E Pohl
Journal:  Lancet       Date:  1978-05-13       Impact factor: 79.321

4.  Effect of labetalol on blood pressure and plasma catecholamine concentrations in patients with phaeochromocytoma.

Authors:  G Reach; M Thibonnier; C Chevillard; P Corvol; P Milliez
Journal:  Br Med J       Date:  1980-05-31

5.  Rapid preparation of a patient with pheochromocytoma with labetolol and magnesium sulfate.

Authors:  R Poopalalingam; E Y Chin
Journal:  Can J Anaesth       Date:  2001-10       Impact factor: 5.063

6.  Pheochromocytoma crisis: the use of magnesium sulfate.

Authors:  Michael F James; Larissa Cronjé
Journal:  Anesth Analg       Date:  2004-09       Impact factor: 5.108

Review 7.  Phaeochromocytoma. Diagnosis, preoperative preparation and anaesthetic management.

Authors:  C J Hull
Journal:  Br J Anaesth       Date:  1986-12       Impact factor: 9.166

Review 8.  Genetics and molecular pathogenesis of pheochromocytoma and paraganglioma.

Authors:  S R Galan; P H Kann
Journal:  Clin Endocrinol (Oxf)       Date:  2013-02       Impact factor: 3.478

9.  Use of magnesium sulphate in the anaesthetic management of phaeochromocytoma: a review of 17 anaesthetics.

Authors:  M F James
Journal:  Br J Anaesth       Date:  1989-06       Impact factor: 9.166

10.  Nonclassic presentation of pheochromocytoma: difficulties in diagnosis and management of the normotensive patient.

Authors:  Adalberto D Gonzalez-Pantaleon; Barbara Simon
Journal:  Endocr Pract       Date:  2008 May-Jun       Impact factor: 3.443

View more
  1 in total

Review 1.  Perioperative Management of Pheochromocytomas and Sympathetic Paragangliomas.

Authors:  Gustavo F C Fagundes; Madson Q Almeida
Journal:  J Endocr Soc       Date:  2022-01-14
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.